Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

947 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis.
Norwood S, Liao J, Hammock BD, Yang GY. Norwood S, et al. Among authors: hammock bd. Am J Transl Res. 2010 Jul 22;2(4):447-57. Am J Transl Res. 2010. PMID: 20733953 Free PMC article.
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL. Yu Z, et al. Among authors: hammock bd. Circ Res. 2000 Nov 24;87(11):992-8. doi: 10.1161/01.res.87.11.992. Circ Res. 2000. PMID: 11090543
Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.
Keserü B, Barbosa-Sicard E, Schermuly RT, Tanaka H, Hammock BD, Weissmann N, Fisslthaler B, Fleming I. Keserü B, et al. Among authors: hammock bd. Cardiovasc Res. 2010 Jan 1;85(1):232-40. doi: 10.1093/cvr/cvp281. Cardiovasc Res. 2010. PMID: 19679679 Free PMC article.
Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice.
Zhang W, Li H, Dong H, Liao J, Hammock BD, Yang GY. Zhang W, et al. Among authors: hammock bd. Anticancer Res. 2013 Dec;33(12):5261-5271. Anticancer Res. 2013. PMID: 24324059 Free PMC article.
Soluble epoxide hydrolase is a therapeutic target for acute inflammation.
Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD. Schmelzer KR, et al. Among authors: hammock bd. Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9772-7. doi: 10.1073/pnas.0503279102. Epub 2005 Jun 30. Proc Natl Acad Sci U S A. 2005. PMID: 15994227 Free PMC article.
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
Seubert JM, Sinal CJ, Graves J, DeGraff LM, Bradbury JA, Lee CR, Goralski K, Carey MA, Luria A, Newman JW, Hammock BD, Falck JR, Roberts H, Rockman HA, Murphy E, Zeldin DC. Seubert JM, et al. Among authors: hammock bd. Circ Res. 2006 Aug 18;99(4):442-50. doi: 10.1161/01.RES.0000237390.92932.37. Epub 2006 Jul 20. Circ Res. 2006. PMID: 16857962 Free PMC article.
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
Keserü B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I. Keserü B, et al. Among authors: hammock bd. FASEB J. 2008 Dec;22(12):4306-15. doi: 10.1096/fj.08-112821. Epub 2008 Aug 25. FASEB J. 2008. PMID: 18725458 Free PMC article.
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.
Imig JD, Hammock BD. Imig JD, et al. Among authors: hammock bd. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. Nat Rev Drug Discov. 2009. PMID: 19794443 Free PMC article. Review.
Soluble epoxide hydrolase in atherosclerosis.
Wang YX, Ulu A, Zhang LN, Hammock B. Wang YX, et al. Curr Atheroscler Rep. 2010 May;12(3):174-83. doi: 10.1007/s11883-010-0108-5. Curr Atheroscler Rep. 2010. PMID: 20425256 Free PMC article. Review.
Soluble epoxide hydrolase inhibitors and heart failure.
Qiu H, Li N, Liu JY, Harris TR, Hammock BD, Chiamvimonvat N. Qiu H, et al. Among authors: hammock bd. Cardiovasc Ther. 2011 Apr;29(2):99-111. doi: 10.1111/j.1755-5922.2010.00150.x. Cardiovasc Ther. 2011. PMID: 20433684 Free PMC article. Review.
947 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback